Orange Book product · Brand (NDA)
ATROVENT HFA
IPRATROPIUM BROMIDE
At a glance
Nov 27, 2004
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 27, 2004
21 yr 10 mo ago
Today
Patent 8474447 expires
Listed drug product patent expiration.
Jan 17, 2030
in 3 yr 8 mo
Pharmaceutical detail
Active ingredient
IPRATROPIUM BROMIDE
Strength
0.021MG/INH
Dosage form
AEROSOL, METERED
Route
INHALATION
TE code
AB
Application
NDA 021527
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1995ATROVENTBrand (NDA)
NDA 020393 · BOEHRINGER INGELHEIM
- 1995ATROVENTBrand (NDA)
NDA 020394 · BOEHRINGER INGELHEIM
- 1993ATROVENTBrand (NDA)
NDA 020228 · BOEHRINGER INGELHEIM
- 1986ATROVENTBrand (NDA)
NDA 019085 · BOEHRINGER INGELHEIM
- 2026IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 217953 · ARMSTRONG PHARMS
- 2025IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 217912 · LUPIN
- 2025IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 217886 · LUPIN
- 2025IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 219222 · RUBICON RESEARCH
- 2024IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 219221 · RUBICON RESEARCH
- 2022IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 215104 · AMNEAL
- 2022IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 215105 · AMNEAL
- 2017IPRATROPIUM BROMIDEGeneric (ANDA)
ANDA 207903 · SUN PHARM
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8474447 | Jan 17, 2030 | in 3 yr 8 mo | ProductDelisted |

